Erratum: Gamma-secretase-dependent and -independent effects of Presenilin1 on β-Catenin.Tcf-4 transcriptional activity (PLoS ONE (2008) 3:12 (e4080) DOI: 10.1371/journal.pone.0004080);Gamma-secretase-dependent and -independent effects of presenilin1 on β-catenin·Tcf-4 transcriptional activity

PLoS ONE

Volumn 3, Issue 12, 2008, Pages

  Raurell, Imma ^a   Codina, Montserrat ^a,b   Casagolda, David ^a   del Valle, Beatriz ^a   Baulida, Josep ^b   García de Herraros, Antonio ^b,c   Duñach, Mireia ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; MYC PROTEIN; NERVE CELL ADHESION MOLECULE; PLAKOGLOBIN; PRESENILIN 1; PROTEIN C FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TCF 4; UNCLASSIFIED DRUG; UVOMORULIN; SECRETASE; T CELL FACTOR PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TRANSCRIPTION REGULATION; ALZHEIMER DISEASE; ANIMAL; CELL CULTURE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MOUSE;

MURINAE;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BETA CATENIN; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; MICE; PRESENILIN-1; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 58149204047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0161515     Document Type: Erratum

References (62)

1. Marjaux E, Hartmann D, De Strooper B (2004) Presenilins in memory, Alzheimer's disease, and therapy. Neuron 42: 189-192.
2. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741-766.
3. Doan A, Thinakaran G, Borchelt DR, Slunt HH, Ratovitsky T, et al. (1996) Protein topology of presenilin 1. Neuron 17: 1023-1030.
4. Baki L, Marambaud P, Efthimiopoulos S, Georgakopoulos A, Wen P, et al. (2001) Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proc Natl Acad Sci U S A 98: 2381-2386.
5. Georgakopoulos A, Marambaud P, Efthimiopoulos S, Shioi J, Cui W, et al. (1999) Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol Cell 4: 893-902.
6. Stahl B, Diehlmann A, Sudhof TC (1999) Direct interaction of Alzheimer's disease-related presenilin 1 with armadillo protein p0071. J Biol Chem 274: 9141-9148.
7. Cox RT, McEwen DG, Myster DL, Duronio RJ, Loureiro J, et al. (2000) A screen for mutations that suppress the phenotype of Drosophila armadillo, the beta-catenin homolog. Genetics 155: 1725-1740.
8. De Strooper B (2003) Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron 38: 9-12.
9. Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, et al. (2002) A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. Embo J 21: 1948-1956.
10. Marambaud P, Wen PH, Dutt A, Shioi J, Takashima A, et al. (2003) A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 114: 635-645.
11. Kaether C, Schmitt S, Willem M, Haass C (2006) Amyloid precursor protein and Notch intracellular domains are generated after transport of their precursors to the cell surface. Traffic 7: 408-415.
12. Reiss K, Maretzky T, Ludwig A, Tousseyn T, de Strooper B, et al. (2005) ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. Embo J 24: 742-752.
13. Fortini ME (2002) Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat Rev Mol Cell Biol 3: 673-684.
14. Teo JL, Ma H, Nguyen C, Lam C, Kahn M (2005) Specific inhibition of CBP/ beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation. Proc Natl Acad Sci U S A 102: 12171-12176.
15. Bentahir M, Nyabi O, Verhamme J, Tolia A, Horre K, et al. (2006) Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J Neurochem 96: 732-742.
16. Noll E, Medina M, Hartley D, Zhou J, Perrimon N, et al. (2000) Presenilin affects arm/beta-catenin localization and function in Drosophila. Dev Biol 227: 450-464.
17. Soriano S, Kang DE, Fu M, Pestell R, Chevallier N, et al. (2001) Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J Cell Biol 152: 785-794.
18. Xia X, Qian S, Soriano S, Wu Y, Fletcher AM, et al. (2001) Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis. Proc Natl Acad Sci U S A 98: 10863-10868.
19. Davis MA, Ireton RC, Reynolds AB (2003) A core function for p120-catenin in cadherin turnover. J Cell Biol 163: 525-534.
20. Giles RH, van Es JH, Clevers H (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1-24.
21. Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487.
22. Polakis P (2000) Wnt signaling and cancer. Genes Dev 14: 1837-1851.
23. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, et al. (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250.
24. Liu C, Li Y, Semenov M, Han C, Baeg GH, et al. (2002) Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108: 837-847.
25. Charpentier E, Lavker RM, Acquista E, Cowin P (2000) Plakoglobin suppresses epithelial proliferation and hair growth in vivo. J Cell Biol 149: 503-520.
26. Miravet S, Piedra J, Miro F, Itarte E, Garcia de Herreros A, et al. (2002) The transcriptional factor Tcf-4 contains different binding sites for beta-catenin and plakoglobin. J Biol Chem 277: 1884-1891.
27. Solanas G, Miravet S, Casagolda D, Castano J, Raurell I, et al. (2004) beta-Catenin and plakoglobin N- and C-tails determine ligand specificity. J Biol Chem 279: 49849-49856.
28. Zhurinsky J, Shtutman M, Ben-Ze'ev A (2000) Differential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin. Mol Cell Biol 20: 4238-4252.
29. Nishimura M, Yu G, Levesque G, Zhang DM, Ruel L, et al. (1999) Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex. Nat Med 5: 164-169.
30. Palacino JJ, Murphy MP, Murayama O, Iwasaki K, Fujiwara M, et al. (2001) Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen synthase kinase-3-independent fashion. J Biol Chem 276: 38563-38569.
31. Zhang Z, Hartmann H, Do VM, Abramowski D, Sturchler-Pierrat C, et al. (1998) Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395: 698-702.
32. Raurell I, Castano J, Franci C, Garcia de Herreros A, Dunach M (2006) Presenilin-1 interacts with plakoglobin and enhances plakoglobin-Tcf-4 association. Implications for the regulation of beta-catenin/ Tcf-4-dependent transcription. J Biol Chem 281: 1401-1411.
33. Castano J, Raurell I, Piedra JA, Miravet S, Dunach M, et al. (2002) Beta-catenin N- and C-terminal tails modulate the coordinated binding of adherens junction proteins to beta-catenin. J Biol Chem 277: 31541-31550.
34. Castano J, Solanas G, Casagolda D, Raurell I, Villagrasa P, et al. (2007) Specific phosphorylation of p120-catenin regulatory domain differently modulates its binding to RhoA. Mol Cell Biol 27: 1745-1757.
35. Roura S, Miravet S, Piedra J, Garcia de Herreros A, Dunach M (1999) Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. J Biol Chem 274: 36734-36740.
36. Miravet S, Piedra J, Castano J, Raurell I, Franci C, et al. (2003) Tyrosine phosphorylation of plakoglobin causes contrary effects on its association with desmosomes and adherens junction components and modulates beta-catenin-mediated transcription. Mol Cell Biol 23: 7391-7402.
37. Herreman A, Hartmann D, Annaert W, Saftig P, Craessaerts K, et al. (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci U S A 96: 11872-11877.
38. Herreman A, Van Gassen G, Bentahir M, Nyabi O, Craessaerts K, et al. (2003) gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation. J Cell Sci 116: 1127-1136.
39. Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, et al. (2000) APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci U S A 97: 3352-3357.
40. Piedra J, Martinez D, Castano J, Miravet S, Dunach M, et al. (2001) Regulation of beta-catenin structure and activity by tyrosine phosphorylation. J Biol Chem 276: 20436-20443.
41. Solanas G, Porta-de-la-Riva M, Agusti C, Casagolda D, Sanchez-Aguilera F, et al. (2008) E-cadherin controls {beta}-catenin and NF-{kappa}B transcriptional activity in mesenchymal gene expression. J Cell Sci 121: 2224-2234.
42. Tomita T, Takikawa R, Koyama A, Morohashi Y, Takasugi N, et al. (1999) C terminus of presenilin is required for overproduction of amyloidogenic Abeta42 through stabilization and endoproteolysis of presenilin. J Neurosci 19: 10627-10634.
43. Doerfler P, Shearman MS, Perlmutter RM (2001) Presenilin-dependent gamma-secretase activity modulates thymocyte development. Proc Natl Acad Sci U S A 98: 9312-9317.
44. Kang DE, Soriano S, Xia X, Eberhart CG, De Strooper B, et al. (2002) Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell 110: 751-762.
45. Dupre-Crochet S, Figueroa A, Hogan C, Ferber EC, Bialucha CU, et al. (2007) Casein kinase 1 is a novel negative regulator of E-cadherin-based cell-cell contacts. Mol Cell Biol 27: 3804-3816.
46. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, et al. (1997) CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A 94: 2927-2932.
47. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
48. Gradl D, Kuhl M, Wedlich D (1999) The Wnt/Wg Signal Transducer beta - Catenin Controls Fibronectin Expression. Mol Cell Biol 19: 5576-5587.
49. Killick R, Pollard CC, Asuni AA, Mudher AK, Richardson JC, et al. (2001) Presenilin 1 independently regulates beta-catenin stability and transcriptional activity. J Biol Chem 276: 48554-48561.
50. Koo EH (2002) The beta-amyloid precursor protein (APP) and Alzheimer's disease: does the tail wag the dog? Traffic 3: 763-770.
51. Serban G, Kouchi Z, Baki L, Georgakopoulos A, Litterst CM, et al. (2005) Cadherins mediate both the association between PS1 and beta-catenin and the effects of PS1 on beta-catenin stability. J Biol Chem 280: 36007-36012.
52. De Strooper B (2007) Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep 8: 141-146.
53. Uemura K, Kuzuya A, Aoyagi N, Ando K, Shimozono Y, et al. (2007) Amyloid beta inhibits ectodomain shedding of N-cadherin via down-regulation of cell-surface NMDA receptor. Neuroscience 145: 5-10.
54. Baki L, Shioi J, Wen P, Shao Z, Schwarzman A, et al. (2004) PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. Embo J 23: 2586-2596.
55. Bryant P, Ploegh H (2004) Class II MHC peptide loading by the professionals. Curr Opin Immunol 16: 96-102.
56. Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428.
57. Prager K, Wang-Eckhardt L, Fluhrer R, Killick R, Barth E, et al. (2007) A structural switch of presenilin 1 by glycogen synthase kinase 3beta-mediated phosphorylation regulates the interaction with beta-catenin and its nuclear signaling. J Biol Chem 282: 14083-14093.
58. Saura CA, Tomita T, Soriano S, Takahashi M, Leem JY, et al. (2000) The nonconserved hydrophilic loop domain of presenilin (PS) is not required for PS endoproteolysis or enhanced abeta 42 production mediated by familial early onset Alzheimer's disease-linked PS variants. J Biol Chem 275: 17136-17142.
59. Chan HM, La Thangue NB (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 114: 2363-2373.
60. Goodman RH, Smolik S (2000) CBP/p300 in cell growth, transformation, and development. Genes Dev 14: 1553-1577.
61. Lalonde R, Strazielle C (2005) PS1 knockin mice with the Japanese I213T mutation: Effects on exploratory activity, motor coordination, and spatial learning. Behavioural Brain Research 162: 182-190.
62. Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, et al. (1999) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 5: 101-106.